Text size

Mixed-martial arts fighters may soon be allowed to test cannabidiol, or CBD, products thanks to a new partnership between Aurora Cannabis and the Ultimate Fighting Championship.

The Canadian marijuana firm and the leading mixed martial-arts organization said Wednesday night that they plan to launch a joint clinical research program into the potential benefits of CBD.

The program seeks to examine the use of CBD as a treatment for pain, inflammation, wound-healing, and recovery for fighters, the companies said in a statement.

CBD is becoming one of the hottest new wellness trends for its soothing benefits. The extract comes from hemp, marijuana’s sister plant that doesn’t contain THC, the chemical that provides the high.

Congress legalized hemp in December, opening the floodgates for marijuana growers and supplement makers to advertise and sell creams, sprays, and similar products that contain CBD. Even Walgreens Boots Alliance (WBA) and CVS Health have jumped on the bandwagon.

Still, the Food and Drug Administration does not yet allow CBD and food and beverages, and recently sent a warning letter to U.S. grower Curaleaf Holdings for selling products online that claimed to treat cancer, Alzheimer’s disease, opioid withdrawal, pain, and pet anxiety, and other conditions or diseases.

The multiphase clinical study will take place at the UFC Performance Institute. Active UFC athletes will be allowed to volunteer to help establish peer-reviewed, publishable research.

Read More: CBD Is the New Marijuana

“Our partnership with UFC is about committing to the science that will educate and advocate,” Aurora (ACB) CEO Terry Booth said in a statement. “We are going to work together to change the way people think, to change the industry, and to launch the first hemp-derived CBD products that are backed by scientific research.”

All products will comply with the UFC’s antidoping program, which are in line with World Anti-Doping Agency and U.S. Department of Agriculture regulations, the companies said.

Editor's Choice

UFC President Dana White called the deal “groundbreaking” for sports, and humanity in general.

“When you think about this the amount of money that’s going to go into the testing and the research of this deal is going to affect our athletes, then it’s going to spill into the NFL, the NBA and soccer,” White said. “And eventually into just regular people like us that work out every day or deal with chronic pain.”

If the research goes well, any new product would be sold under the companies’ new ROAR Sports brand, and be designated the “Official CBD product of UFC.”

The announcement, which came after the market closed Wednesday, didn’t provide a lift for Aurora stock. In Thursday morning trading, shares were down 5 cents to $6.50.

Write to Connor Smith at connor.smith@barrons.com